Navigation Links
Antibiotics Procurement Research Report Now Available from IBISWorld

Los Angeles, CA (PRWEB) October 27, 2013

Antibiotic products have a buyer power score of 3.3 out of 5.0. A high score indicates a competitive advantage for the buyers. The score reflects current negative pricing trends and moderate rate of bargain power, but is positively influenced by the ease of purchasing complexity and strong purchasing confidence. According to IBISWorld procurement analyst Anna Son, “prices for antibiotics have fluctuated over the past three years as a result of rising regulatory compliance costs and generics competition”. Due to the patent expiry of many blockbuster drugs, increased availability of generic antibiotics, which are generally far less expensive than their brand-name counterparts, has driven down the average price of these products. Nonetheless, a limited number of suppliers of antibiotics that treat rare diseases have kept prices high.

The cost associated with switching suppliers of antibiotics varies depending on the type of supplier. “For example, buyers can expect lower costs associated with switching suppliers of commonly used antibiotics, such as amoxicillin, because of their instant availability and low buying lead time”, says Son. This provides buyers with the opportunity to restock their inventory in a relatively short time frame, barring contract negotiations. In this case, buyers have greater leverage in negotiating contracts. On the contrary, buyers are more likely to incur higher costs when they switch suppliers of antibiotics that treat rare disease, especially when there are only a small number of suppliers of that particular drug. As such, suppliers of rare antibiotics have greater negotiating power over buyers.

Furthermore, antibiotics manufacturers typically capture high profit margins. High margins usually give buyers room to negotiate for lower prices. However, the low availability of substitutes, a moderate level of market share concentration and the high specialization among suppliers limit the buyers' negotiating power. In addition, the antibiotics market is mature and has a low level of financial risk given its established place in the supply chain. The three largest companies in the industry are AstraZeneca, Cubist Pharmaceuticals and GlaxoSmithKline.

For more information, visit IBISWorld’s Antibiotics procurement research report page.

Follow IBISWorld on Twitter:!/IBISWorld
Friend IBISWorld on Facebook:

IBISWorld Procurement Report Key Topics

This report is intended to help buyers of antibiotic products. Antibiotics, also known as antibacterials, are types of medications that destroy or slow the growth of microorganisms such as bacteria, fungi and parasites. Most antibiotics have two names, the brand name, created by the original drug manufacturer, and a generic name, which is based on the antibiotic's chemical structure. Suppliers of antibiotics include manufacturers, wholesalers and retailers. This report excludes antibiotic products for veterinary use.

Executive Summary
Pricing Environment
Price Fundamentals
Benchmark Price
Pricing Model
Price Drivers
Recent Price Trend
Price Forecast
Product Characteristics
Product Life Cycle
Total Cost of Ownership
Product Specialization
Substitute Goods
Quality Control
Supply Chain & Vendors
Supply Chain Dynamics
Supply Chain Risk
Competitive Environment
Market Share Concentration
Vendor Financial Benchmarks
Switching Costs
Purchasing Process
Buying Basics
Buying Lead Time
Selection Process
Key RFP Elements
Negotiation Questions
Buyer Power Factors
Key Statistics

About IBISWorld Inc.
IBISWorld is one of the world's leading publishers of business intelligence, specializing in Industry research and Procurement research. Since 1971, IBISWorld has provided thoroughly researched, accurate and current business information. With an extensive online portfolio, valued for its depth and scope, IBISWorld’s procurement research reports equip clients with the insight necessary to make better purchasing decisions, faster. Headquartered in Los Angeles, IBISWorld Procurement serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit or call 1-800-330-3772.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Antibiotics Linked to Retinal Detachment Risk
2. Researchers find evidence of banned antibiotics in poultry products
3. Study Finds Antibiotics Best for Appendicitis
4. FDA Seeks to Limit Antibiotics in Animal Feed
5. Timing of antibiotics important in reducing infections after C-section
6. Two Antibiotics Linked to Liver Injury in Elderly
7. Antibiotics Dont Ease Coughs in Kids With Common Cold: Study
8. Electronic visits offer accurate diagnoses, may lead to overprescribing of antibiotics
9. BioMAP screening procedure could streamline search for new antibiotics
10. Frog-in-bucket-of-milk folklore leads to potential new antibiotics
11. Evidence insufficient to recommend routine antibiotics for joint replacement patients
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... the 1980s we have seen vast improvements in scientific research and discoveries, leading ... strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... , ... XTC Semifinals 2016 - CES, Las Vegas, Nevada - ... CES 2016, the world’s largest Consumer Electronic Show, where they will present to a ... of Pacific Investments Veronica Serra, and venture capitalist Tim Draper among many other top ...
(Date:12/1/2015)... ... 2015 , ... SonaCare Medical congratulates the University College London ... on November 18th. This prestigious award recognizes annually organizations that cultivate truly innovative ... medical landscape. , The UCLH team won the award for their innovative approach ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , December 1, 2015 ... new market research report "Nucleic Acid Labeling Market by ... Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, ... published by MarketsandMarkets, The global market is expected to ... Million in 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , December 1, 2015 Russia ... clinical trials. 70% of new drugs registered in Europe ... Russia . --> Russia has always been ... of new drugs registered in Europe in 2015 ... --> Russia has always been a country ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
Breaking Medicine Technology: